Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Antonio Ferreira-Pereira is active.

Publication


Featured researches published by Antonio Ferreira-Pereira.


The Journal of Infectious Diseases | 2004

Inhibition of heme aggregation by chloroquine reduces Schistosoma mansoni infection

Marcus F. Oliveira; Joana C.P d'Avila; Antônio Jorge Tempone; Juliana B. R. Correâ Soares; Franklin David Rumjanek; Antonio Ferreira-Pereira; Sergio T. Ferreira; Pedro L. Oliveira

Adult Schistosoma mansoni digest large amounts of host hemoglobin and release potentially toxic heme inside their guts. We have previously demonstrated that free heme in S. mansoni is detoxified through aggregation, forming hemozoin (Hz). Possible mechanisms of heme aggregation and the effects of chloroquine (CLQ) on formation of Hz and on the viability of this parasite have now been investigated. Different fractions isolated from S. mansoni, such as crude whole-worm homogenates, total lipid extracts, and Hz itself promoted heme aggregation in vitro in a CLQ-sensitive manner. Treatment of S. mansoni-infected mice with CLQ led to remarkable decreases in total protein, Hz content, and viability of the worms, as well as in parasitemia and deposition of eggs in mouse livers. These results indicate that inhibition of formation of Hz in S. mansoni, by CLQ, led to an important decrease in the overall severity of experimental murine schistosomiasis. Taken together, the results presented here suggest that formation of Hz is a major mechanism of heme detoxification and a potential target for chemotherapy in S. mansoni.


Journal of Biological Chemistry | 2003

Three-dimensional reconstruction of the Saccharomyces cerevisiae multidrug resistance protein Pdr5p

Antonio Ferreira-Pereira; Sergio Marco; Joseph Nader; André Goffeau; Jean Louis Rigaud

Pdr5p, the major multidrug exporter inSaccharomyces cerevisiae, is a member of the ATP-binding cassette (ABC) superfamily. Pdr5p shares similar mechanisms of substrate recognition and transport with the human MDR1-Pgp, despite an inverted topology of transmembrane and ATP-binding domains. The hexahistidine-tagged Pdr5p multidrug transporter was highly overexpressed in yeast strains where other ABC genes have been deleted. After solubilization and purification, the 160-kDa recombinant Pdr5p has been reconstituted into a lipid bilayer. Controlled detergent removal from Pdr5p-lipid-detergent micelles allowed the production of peculiar square-shaped particles coexisting with liposomes and proteoliposomes. These particles having 11 nm in side were well suited for single particle analysis by electron microscopy. From such analysis, a computed volume has been determined at 25-Å resolution, giving insight into the structural organization of Pdr5p. Comparison with the reported structures of different bacterial ABC transporters was consistent with a dimeric organization of Pdr5p in the square particles. Each monomer was composed of three subregions corresponding to a membrane region of about 50 Å in height that joins two well separated protruding stalks of about 40 Å in height, ending each one with a cytoplasmic nucleotide-binding domain (NBD) lobe of about 50–60 Å in diameter. The three-dimensional reconstruction of Pdr5p revealed a close arrangement and a structural asymmetric organization of the two NBDs that appeared oriented perpendicularly within a monomer. The existence of different angular positions of the NBDs, with respect to the stalks, suggest rotational movements during the catalytic cycle.


PLOS Neglected Tropical Diseases | 2009

Interference with Hemozoin Formation Represents an Important Mechanism of Schistosomicidal Action of Antimalarial Quinoline Methanols

Juliana B. R. Correa Soares; Diego Menezes; Marcos A. Vannier-Santos; Antonio Ferreira-Pereira; Giulliana T. Almeida; Thiago M. Venancio; Sergio Verjovski-Almeida; Vincent K. Zishiri; David J. Kuter; Roger Hunter; Timothy J. Egan; Marcus F. Oliveira

Background The parasitic trematode Schistosoma mansoni is one of the major causative agents of human schistosomiasis, which afflicts 200 million people worldwide. Praziquantel remains the main drug used for schistosomiasis treatment, and reliance on the single therapy has been prompting the search for new therapeutic compounds against this disease. Our group has demonstrated that heme crystallization into hemozoin (Hz) within the S. mansoni gut is a major heme detoxification route with lipid droplets involved in this process and acting as a potential chemotherapeutical target. In the present work, we investigated the effects of three antimalarial compounds, quinine (QN), quinidine (QND) and quinacrine (QCR) in a murine schistosomiasis model by using a combination of biochemical, cell biology and molecular biology approaches. Methodology/Principal Findings Treatment of S. mansoni-infected female Swiss mice with daily intraperitoneal injections of QN, and QND (75 mg/kg/day) from the 11th to 17th day after infection caused significant decreases in worm burden (39%–61%) and egg production (42%–98%). Hz formation was significantly inhibited (40%–65%) in female worms recovered from QN- and QND-treated mice and correlated with reduction in the female worm burden. We also observed that QN treatment promoted remarkable ultrastructural changes in male and female worms, particularly in the gut epithelium and reduced the granulomatous reaction to parasite eggs trapped in the liver. Microarray gene expression analysis indicated that QN treatment increased the expression of transcripts related to musculature, protein synthesis and repair mechanisms. Conclusions The overall significant reduction in several disease burden parameters by the antimalarial quinoline methanols indicates that interference with Hz formation in S. mansoni represents an important mechanism of schistosomicidal action of these compounds and points out the heme crystallization process as a valid chemotherapeutic target to treat schistosomiasis.


Infection and Immunity | 2008

Trypanosoma cruzi Infection Is Enhanced by Vector Saliva through Immunosuppressant Mechanisms Mediated by Lysophosphatidylcholine

Rafael D. Mesquita; Alan Brito Carneiro; André Báfica; Felipe Gazos-Lopes; Christina Maeda Takiya; Thaïs Souto-Padrón; Danielle P. Vieira; Antonio Ferreira-Pereira; Igor C. Almeida; Rodrigo T. Figueiredo; Bárbara N. Porto; Marcelo T. Bozza; Aurélio V. Graça-Souza; Angela H. Lopes; Georgia C. Atella; Mário A.C. Silva-Neto

ABSTRACT Trypanosoma cruzi, the etiological agent of Chagas disease, is transmitted by bug feces deposited on human skin during a blood meal. However, parasite infection occurs through the wound produced by insect mouthparts. Saliva of the Triatominae bug Rhodnius prolixus is a source of lysophosphatidylcholine (LPC). Here, we tested the role of both triatomine saliva and LPC on parasite transmission. We show that vector saliva is a powerful inducer of cell chemotaxis. A massive number of inflammatory cells were found at the sites where LPC or saliva was inoculated into the skin of mice. LPC is a known chemoattractant for monocytes, but neutrophil recruitment induced by saliva is LPC independent. The preincubation of peritoneal macrophages with saliva or LPC increased fivefold the association of T. cruzi with these cells. Moreover, saliva and LPC block nitric oxide production by T. cruzi-exposed macrophages. The injection of saliva or LPC into mouse skin in the presence of the parasite induces an up-to-sixfold increase in blood parasitemia. Together, our data suggest that saliva of the Triatominae enhances T. cruzi transmission and that some of its biological effects are attributed to LPC. This is a demonstration that a vector-derived lysophospholipid may act as an enhancing factor of Chagas disease.


Drug Design Development and Therapy | 2013

New structure-activity relationships of chalcone inhibitors of breast cancer resistance protein: Polyspecificity toward inhibition and critical substitutions against cytotoxicity

Luciana P. Rangel; Evelyn Winter; Charlotte Gauthier; Raphaël Terreux; Louise Domeneghini Chiaradia-Delatorre; Alessandra Mascarello; Ricardo José Nunes; Rosendo A. Yunes; Tania Beatriz Creczynski-Pasa; Sira Macalou; Doriane Lorendeau; H. Baubichon-Cortay; Antonio Ferreira-Pereira; Attilio Di Pietro

Adenosine triphosphate-binding cassette subfamily G member 2 (ABCG2) plays a major role in cancer cell multidrug resistance, which contributes to low eifficacy of chemotherapy. Chalcones were recently found to be potent and specific inhibitors, but unfortunately display a significant cytotoxicity. A cellular screening against ABCG2-mediated mitoxantrone efflux was performed here by flow cytometry on 54 chalcone derivatives from three different series with a wide panel of substituents. The identified leads, with submicromolar IC50 (half maximal inhibitory concentration) values, showed that the previously identified 2′-OH-4′,6′-dimethoxyphenyl, as A-ring, could be efficiently replaced by a 2′-naphthyl group, or a 3′,4′-methylenedioxyphenyl with lower affinity. Such a structural variability indicates 3polyspecificity of the multidrug transporter for inhibitors. At least two methoxyl groups were necessary on B-ring for optimal inhibition, but substitution at positions 3, 4, and 5 induced cytotoxicity. The presence of a large O-benzyl substituent at position 4 and a 2′-naphthyl as A-ring markedly decreased the cytotoxicity, giving a high therapeutic ratio, which constitutes a critical requirement for future in-vivo assays in animal models.


Journal of Natural Products | 2011

Oroidin Inhibits the Activity of the Multidrug Resistance Target Pdr5p from Yeast Plasma Membranes

Fernanda R. da Silva; Ana Claudia Tessis; Patricia F. Ferreira; Luciana P. Rangel; Aline S. Garcia-Gomes; Fabio R. Pereira; Roberto G. S. Berlinck; Guilherme Muricy; Antonio Ferreira-Pereira

Oroidin was isolated from the marine sponge Agelassventres and inhibited the activity and function of Pdr5p, an enzyme responsible for the multidrug resistance phenotype in Saccharomyces cerevisiae. This compound may help in the development of new drugs that reverse this dangerous phenotype of pathogenic yeast and fungi.


Journal of Antimicrobial Chemotherapy | 2017

Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?

Mariana I. D. S. Xisto; Rita Caramalho; Débora Afonso Silva Rocha; Antonio Ferreira-Pereira; Bettina Sartori; Eliana Barreto-Bergter; Maria de Lourdes Junqueira; Cornelia Lass-Flörl; Michaela Lackner

Objectives Candidaemia is a public health problem mainly in hospitalized individuals worldwide. In Brazil, Candida albicans is the most prevalent species that causes candidaemia, followed by Candida tropicalis and Candida parapsilosis . Few data on the abundance of antifungal resistance are available for Latin America. Methods We analysed the frequency of azole and echinocandin resistance in Candida isolates ( n  =   75) collected between 2012 and 2014 at the University Hospital of Federal University of Juiz de Fora (Brazil). The primary targets erg11 (azoles) and fks1 (echinocandins) were sequenced and modelled at the protein level. Antifungal susceptibility testing was performed according to CLSI (M27-A3 and M27-S4) and according to EUCAST. Results The three most frequent species were C. albicans (38.0%), C. tropicalis (30.0%) and Candida glabrata (17.0%). Azole resistance was observed in 27.0% of all Candida isolates, while 20.0% of all isolates were echinocandin resistant. A novel mutation in erg11 at location K143R was found to be associated with phenotypically pan-azole-resistant C. tropicalis isolates. This mutation maps near the active binding site of erg11 and is likely to confer pan-azole resistance to C. tropicalis . Conclusions A novel point mutation (K143R) located in the erg11 gene of C. tropicalis was found in pan-azole-resistant strains. According to our protein homology model, it is very likely that the mutation K143R causes pan-azole resistance in C. tropicalis . Moreover, an up-regulation of ABC transporters was observed, which can add up to a pan-azole-resistant phenotype.


Fems Yeast Research | 2010

Inhibitory effects of gallic acid ester derivatives on Saccharomyces cerevisiae multidrug resistance protein Pdr5p

Luciana P. Rangel; Márcio Fritzen; Rosendo A. Yunes; Paulo César Leal; Tânia B. Creczynski-Pasa; Antonio Ferreira-Pereira

Overexpression of the Saccharomyces cerevisiae ABC transporter Pdr5p confers resistance to a range of structurally unrelated xenobiotics. This property allows Pdr5p to be used as a target for novel multidrug resistance reversal reagents or chemosensitizers. Herein, we report the effects of gallic acid derivatives with substitutions either on the ester moiety or in the benzene ring on the activity of Pdr5p. Compounds with a longer side chain (8-16 carbons) resulted in greater inhibition of Pdr5p ATPase. Derivatives with side chains of 8-12 carbons that retained hydroxyl groups on the benzene ring extensively inhibited Pdr5p ATPase activity. These compounds almost completely inhibited the efflux of the Pdr5p fluorescent substrate Rhodamine 6G and at 25 muM chemosensitized the Pdr5p-overexpressing strain AD124567 to fluconazole (0.4 mg mL(-1)). Gallic acid derivatives may be a new class of Pdr5p inhibitors.


Revista Brasileira De Farmacognosia-brazilian Journal of Pharmacognosy | 2008

Effect of different extracts from the Brazilian Atlantic Forest on the Pdr5p ATPase activity

Luciana P. Rangel; Lisandra Ferreira de Abreu; Ana Rodrigues de Andrade; Suzana G. Leitão; Gilda Guimarães Leitão; Antonio Ferreira-Pereira

In the current study, we tested the effect of 27 plant extracts and fractions from different botanical families on the activity of Pdr5p from yeast plasma membrane, responsible for the multidrug resistance phenotype in yeast cells. Some of the extracts were able to produce a good inhibition in the fixed concentration (200 µg/mL) and were selected for a deeper investigation. Dose-response curves were obtained for the crude ethanol extracts of Bathysa australis (A. St.-Hill.) Benth. & Hook f., Mabea fistulifera Mart. and Virola oleifera (Schott) A. C. Sm. with concentrations ranging up to 400 µg/mL. The lower IC50 value was obtained for Virola oleifera, 22.8 µg/mL, followed by Bathysa australis, 35.3 µg/mL, and Mabea fistulifera, 42.5 µg/mL. After fractionation of the crude extracts by liquid-liquid partition with different organic solvents and each fraction was tested again, only some of the fractions retained the ability to inhibit the enzymatic activity. When analyzed by HPLC/DAD, the active fractions showed the presence of flavonoid derivatives, already reported for their ability to inhibit Pdr5p ATPase activity, as well as other classes of secondary metabolites such as lignans and alkaloids.


Journal of Agricultural and Food Chemistry | 2012

Constituents of Hondurian Propolis with Inhibitory Effects on Saccharomyces cerevisiae Multidrug Resistance Protein Pdr5p

Cinzia Lotti; Anna Lisa Piccinelli; Carolina Arevalo; Ines Ruiz; Gabriellen Menezes Migliani de Castro; Leandro Figueira Reis de Sá; Ana Claudia Tessis; Antonio Ferreira-Pereira; Luca Rastrelli

Chemical investigation of a propolis sample collected in Honduras has led to the isolation of the new (E,Z)-cinnamyl cinnamate (2) together with 14 known compounds: 6 cinnamic ester derivatives, 2 flavanones, 1 chalcone, 2 triterpenes, and 3 aromatic acids. Structural determination was accomplished by spectroscopic analysis, particularly two-dimensional (2D) nuclear magnetic resonance (NMR) and electrospray ionization-tandem mass spectrometry (ESI-MS/MS) techniques. Futhermore, we checked the ability of the propolis extract and the most representative compounds of each class (1, 5, 8, and 10) to inhibit the activity of Pdr5p, a protein responsible for a multidrug resistance phenotype in yeast. The present study appears to be the first report on Honduras propolis. Isolated cinnamic ester derivatives indicated the possible relation between Honduras propolis and the genus Liquidambar .

Collaboration


Dive into the Antonio Ferreira-Pereira's collaboration.

Top Co-Authors

Avatar

Leandro Figueira Reis de Sá

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Luciana P. Rangel

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Ana Claudia Tessis

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Angela H. Lopes

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Helena M. Scofano

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruno A. Sousa

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar

Celuta Sales Alviano

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Débora Afonso Silva Rocha

Federal University of Rio de Janeiro

View shared research outputs
Researchain Logo
Decentralizing Knowledge